About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Biomedical Research Group in Gynaecology is a multidisciplinary team made up of clinical specialists in gynaecology and pathology and basic and translational researchers. Our research is clearly translational. Although we take into account the obvious importance of understanding the mechanism at the cellular and molecular level and try to incorporate it into our research, our research is always focused on having a direct applicability to patients and their clinical benefit. On our way to transferring scientific results to clinical practice, we promote innovation and entrepreneurship.
Our group comprises four main research groups, which are closely connected: The clinical research group devoted mainly to clinical projects in all gynaecological cancers; and three translational research groups dedicated to ovarian cancer; endometrial cancer and endometriosis; diseases of the lower female genital tract.
IP: Eva Colas Ortega Collaborators: Beatriz Villafranca Magdalena, Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 119567 Reference: FI21/00271 Duration: 01/01/2022 - 31/12/2025
IP: Meritxell Genesca Ferrer Collaborators: Vicente Descalzo Jorro, Josep Castellví Vives, Laura Mañalich Barrachina Funding agency: Instituto de Salud Carlos III Funding: 171820 Reference: PI20/00160 Duration: 01/01/2021 - 30/06/2025
IP: Matilde Lleonart Pajarin Collaborators: Yoelsis Garcia Mayea, Jordi Temprana Salvador, Angel García Jiménez, Josep Castellví Vives, Laia Josa Culleré, Marina Bataller Fernández Funding agency: Instituto de Salud Carlos III Funding: 183920 Reference: PI20/00556 Duration: 01/01/2021 - 30/06/2025
IP: Carlota Rodó Rodríguez Collaborators: Pablo García Manau, Berta Serrano Sanchez, Francisco Barranco Martinez, Mireia Armengol Alsina, Ester Del Barco Martínez Funding agency: Instituto de Salud Carlos III Funding: 162140 Reference: PI21/00601 Duration: 01/01/2022 - 30/06/2026
PMID: 37174081 Journal: Cancers Year: 2023 Reference: Cancers (Basel). 2023 May 4;15(9):2612. doi: 10.3390/cancers15092612. Impact factor: Publication type: Paper in international publication Authors: Arencibia-Sanchez, Octavio; Beric, Duska; Cabezas-Lopez, Elena; Cabrera, Silvia; Coronado, Pluvio; Diaz-Feijoo, Berta; Gil-Ibanez, Blanca; Gilabert-Estelles, Juan; Laseca-Modrego, Maria; Lorenzo, Cristina et al. DOI: 10.3390/cancers15092612
PMID: 37127326 Journal: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Year: 2023 Reference: Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429. Impact factor: Publication type: Paper in international publication Authors: Bernabe, Sandra Rubio; Centeno, Carlos; Chargari, Cyrus; Cibula, David; Felix, Ana; Fischerova, Daniela; Jahnn-Kuch, Daniela; Joly, Florence; Kohler, Christhardt; Lax, Sigurd et al. DOI: 10.1136/ijgc-2023-004429
PMID: 37919293 Journal: Cell Death & Disease Year: 2023 Reference: Cell Death Dis. 2023 Nov 2;14(11):715. doi: 10.1038/s41419-023-06229-6. Impact factor: Publication type: Paper in international publication Authors: Alari-Pahissa, Elisenda; Artigas, Antoni; Blot, Pierre-Louis; Bolinaga-Ayala, Idoia; Cartailler, Jerome; Chousterman, Benjamin G; Colas, Eva; Denizli, Melek; Espinosa-Gil, Sergio; Faundez-Vidiella, Claudia et al. DOI: 10.1038/s41419-023-06229-6
PMID: 37926340 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2023 Reference: Rev Esp Cardiol (Engl Ed). 2023 Nov 3:S1885-5857(23)00284-0. doi: 10.1016/j.rec.2023.11.001. Impact factor: Publication type: Paper in international publication Authors: Alari-Pahissa, Elisenda; Almenar-Bonet, Luis; Atienza, Felipe; Aurelio Sarralde-Aguayo, Jose; Baguda, Javier De Juan; Barge-Caballero, Eduardo; Blasco-Peiro, Teresa; Bolinaga-Ayala, Idoia; Camino, Manuela; Carlos Sanchez-Salado, Jose et al. DOI: 10.1016/j.rec.2023.11.001
PMID: 35505629 Journal: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA Year: 2022 Reference: Acta Obstet Gynecol Scand. 2022 Jul;101(7):803-808. doi: 10.1111/aogs.14371. Epub 2022 May 3. Impact factor: 3.636 Publication type: Paper in international publication Authors: Serrano, Berta, Mendoza, Manel, Garcia-Aguilar, Paula, Bonacina, Erika, Garcia-Ruiz, Itziar, Garcia-Manau, Pablo, Gil, Judit, Armengol-Alsina, Mireia, Fernandez-Hidalgo, Nuria, Sulleiro, Elena et al. DOI: 10.1111/aogs.14371
PMID: 35454880 Journal: Cancers Year: 2022 Reference: Cancers (Basel). 2022 Apr 13;14(8). pii: cancers14081974. doi: 10.3390/cancers14081974. Impact factor: 6.639 Publication type: Paper in international publication Authors: Diaz-Feijoo, Berta, Acosta, Ursula, Torne, Aureli, Gil-Ibanez, Blanca, Hernandez, Alicia, Domingo, Santiago, Bradbury, Melissa, Gil-Moreno, Antonio et al. DOI: 10.3390/cancers14081974
PMID: 35441353 Journal: Clinical & Translational Oncology Year: 2022 Reference: Clin Transl Oncol. 2022 Aug;24(8):1605-1614. doi: 10.1007/s12094-022-02808-9. Epub 2022 Apr 19. Impact factor: 3.405 Publication type: Review in international publication Authors: Gomez-Hidalgo, Natalia R, Acosta, Ursula, Rodriguez, Tomas Gomez, Mico, Soraya, Verges, Ramona, Conesa, Vicente Bebia, Bradbury, Melissa, Perez-Hoyos, Santiago, Perez-Benavente, Asuncion, Gil-Moreno, Antonio et al. DOI: 10.1007/s12094-022-02808-9
PMID: 35332556 Journal: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS Year: 2022 Reference: Int J Gynaecol Obstet. 2022 Mar 25. doi: 10.1002/ijgo.14192. Impact factor: 3.561 Publication type: Paper in international publication Authors: Armengol, Mireia, Carreras, Elena, Moreano, Gabriela, Tusquets, Cristina, Garcia-Manau, Pablo, Mendoza, Manel, Bonacina, Erika, Serrano, Berta, Ricart, Marta, Martin, Lourdes et al. DOI: 10.1002/ijgo.14192
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.
From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer
